Literature DB >> 1079460

[Lymphocyte in chronic lymphatic leukemia].

G Brittinger, W Augener, K Bremer, G Cohnen, S Dabag, K Fischer, E König, P Meusers.   

Abstract

In patients with chronic lymphatic leukemia (CLL) the majority of peripheral blood lymphocytes was characterized as B cells by surface membrane markers. Ultrastructural studies revealed a reduction of the cytoplasmic area. Furthermore, the number of lysosomes was diminished corresponding to a decreased activity of lysosomal hydrolases. Increasing blood lymphocytosis was paralleled by an increase of the percentage of lysosome-poor lymphocytes. Response of CLL lymphocytes to in vitro stimulation with PHA and PWM was either lacking or diminished and/or delayed, and the number of transformed cells was reduced. Thus, the majority of CLL lymphocytes appears to represent both morphologically and functionally abnormal neoplastic b cells. During the early and later phase of stimulation the mitogen-reactive CLL lymphocytes exhibited alterations of the lysosomal apparatus similar to those observed in normal cells. The reactive lymphocytes may be derived from residual populations of normally functioning T and/or B cells. However, the neoplastic cells may also be able to respond to the mitogens. In vivo studies showed impaired kinetics of circulation and recirculation of CLL B lymphocytes, whereas the T cells were normal in this respect.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1079460     DOI: 10.1007/bf01633649

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  51 in total

1.  Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukemia.

Authors:  D Catovsky; E Tripp; A V Hoffbrand; E König; G Cohnen; G Brittinger; S D Douglas; S S Fröland; P Stavem
Journal:  Lancet       Date:  1972-04-08       Impact factor: 79.321

2.  Acid phosphatase cytochemistry of mitrogen-transformed normal and chronic lymphocytic leukemia lymphocytes.

Authors:  G Cohnen; S D Douglas; E König; G Brittinger
Journal:  Exp Cell Res       Date:  1973-08       Impact factor: 3.905

3.  Lymphocyte lysosomes and lysosomal enzymes in chronic lymphocytic leukemia.

Authors:  S D Douglas; G Cohnen; E König; G Brittinger
Journal:  Blood       Date:  1973-04       Impact factor: 22.113

4.  Binding of concanavalin A to rat, normal human, and chronic lymphatic leukemia lymphocytes.

Authors:  A Novogrodsky; M Biniamnov; B Ramot; E Katchalski
Journal:  Blood       Date:  1972-09       Impact factor: 22.113

5.  Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases.

Authors:  J L Preud'homme; M Seligmann
Journal:  Blood       Date:  1972-12       Impact factor: 22.113

6.  Surface immunoglobulin-moieties on lymphoid cells.

Authors:  E Klein; T Eskeland; M Inoue; R Strom; B Johansson
Journal:  Exp Cell Res       Date:  1970-09       Impact factor: 3.905

7.  Immunoglobulins as cell receptors.

Authors:  B Pernis; L Forni; L Amante
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

8.  [Lysosomal enzymes in lymphocytes. I. Lymphoreticular diseases: comparison of the enzyme content (acid phosphatase, beta-glucuronidase) in unstimulated lymphocytes with blastic transformation after stimulation with phytohemagglutinin beta-Glucuronidase in vitro].

Authors:  G Brittinger; E König; G Cohnen; H G Aberle
Journal:  Acta Haematol       Date:  1970       Impact factor: 2.195

9.  Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia.

Authors:  H M Grey; E Rabellino; B Pirofsky
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808

10.  Studies on lysosomes. XII. Redistribution of acid hydrolases in human lymphocytes stimulated by phytohemagglutinin.

Authors:  R Hirschhorn; G Brittinger; K Hirschhorn; G Weissmann
Journal:  J Cell Biol       Date:  1968-05       Impact factor: 10.539

View more
  4 in total

1.  PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.

Authors:  K H Robert
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

2.  B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia.

Authors:  K H Robèrt; E Möller; G Gahrton; H Eriksson; B Nilsson
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

3.  [Chronic lymphatic leukemia of B-cell type: clinical and morphological investigations for diagnostic differentiation (author's transl)].

Authors:  J D Schwarzmeier; T Radaszkiewicz; W Graninger; F Hofer; E Paietta; C Moser
Journal:  Klin Wochenschr       Date:  1981-12-01

4.  Lipid composition of human lymphocytes in patients with chronic lymphatic leukaemia and with blocked T cell activity.

Authors:  H Smyth; A Corrigan; R O'Kennedy
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.